Tilorone hydrochloride at a concentration of 10 ,ug/ml very efficiently inhibited herpes simplex virus growth in BSC1 cells when the virus is infected at a low multiplicity of infection. The adsorption of the virus was not affected by the drug, and the penetration of the deoxyribonucleic acid of the input virus into the cytoplasm and nuclei proceeded normally when tilorone hydrochloride was present. However, newly synthesized viral deoxyribonucleic acid was not detectable under these conditions, there was a remarkable decrease in the rate of viral polypeptide synthesis, and virus particles were not formed. The inhibition of herpesvirus growth by tilorone hydrochloride was absolutely dependent on the presence of the drug in the cultures. Pretreatment of the cells with the drug did not result in resistance to herpesvirus infection after the removal of the drug.Tilorone hydrochloride, a dihydrochloride salt of 2,7-bis[2-(diethylamino)ethoxy]fluoren-9-one (2), reduces infection of mice with Semliki Forest, vesicular stomatitis, encephalomyocarditis, mengo, influenza A and B, and herpes simplex viruses. It also inhibits tail lesions by nonlethal doses of vaccinia virus (6,14). It has been suggested that in vivo antiviral activity caused by tilorone results from induction of interferon (6,14,22). Tilorone also has antitumor activity (1,3,18,19) and reduces the deoxyribonucleic acid (DNA) polymerase activity associated with ribonucleic acid tumor viruses (5).Recently, we showed that tilorone hydrochloride (10 ,ug/ml) very efficiently inhibits the growth of herpes simplex virus type 1 in BSC1 cells (E. Katz, E. Margalith, and B. Winer, J. Gen. Virol., in press). Since no direct inactivation of virus infectivity was observed after incubation of virus suspension with the drug, an intracellular mechanism of antiviral action was suggested. The inhibition of herpesvirus growth was more effective when the multiplicity of infection was less than 1 and when the drug was added early in the course of infection.The aim of the present study was to examine the intracellular antiviral action of tilorone hydrochloride and to observe the synthesis of macromolecules of herpes simplex virus in BSC1 cells in the presence of the drug.MATERIALS AND METHODS Virus. Herpes simplex virus type 1 HF was obtained from ATCC. Virus stock was kept at 4 C.Cell cultures. BSC1 cells were grown in M199 supplemented with 10% inactivated calf serum in 60-mm plastic petri dishes (Nunc, Denmark). The dishes were incubated at 37 C in a humidified atmosphere supplied with 5% CO2. Infection procedure. Monolayers of BSC1 cells were infected with 0.3 ml of virus suspension at a multiplicity of infection of 0.5. After 1 h at 37 C the monolayers were washed with saline buffer, and 5 ml of M199 supplemented with 2% calf serum was added.Plaque assay. Monolayers of BSC1 cells were infected with 0.2 or 0.3 ml of virus dilution. After 1 h at 37 C, the cells were overlaid with Eagle medium containing 1% special Agar Noble (Difco Laboratories, Detroit, Mich.) and 5% inact...